Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HC21
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 92 | 96 | PF00656 | 0.642 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.641 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.645 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.463 |
CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 168 | 170 | PF00082 | 0.624 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.652 |
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.639 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.373 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.792 |
DEG_SPOP_SBC_1 | 23 | 27 | PF00917 | 0.492 |
DOC_CKS1_1 | 231 | 236 | PF01111 | 0.755 |
DOC_CYCLIN_yCln2_LP_2 | 228 | 234 | PF00134 | 0.623 |
DOC_MAPK_gen_1 | 129 | 140 | PF00069 | 0.602 |
DOC_MAPK_gen_1 | 43 | 51 | PF00069 | 0.381 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.596 |
DOC_USP7_UBL2_3 | 125 | 129 | PF12436 | 0.394 |
DOC_USP7_UBL2_3 | 36 | 40 | PF12436 | 0.669 |
DOC_USP7_UBL2_3 | 43 | 47 | PF12436 | 0.523 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.741 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.714 |
LIG_14-3-3_CanoR_1 | 211 | 220 | PF00244 | 0.618 |
LIG_14-3-3_CanoR_1 | 58 | 67 | PF00244 | 0.396 |
LIG_Actin_WH2_2 | 110 | 127 | PF00022 | 0.636 |
LIG_Actin_WH2_2 | 134 | 151 | PF00022 | 0.373 |
LIG_AP2alpha_1 | 183 | 187 | PF02296 | 0.612 |
LIG_BIR_III_2 | 153 | 157 | PF00653 | 0.425 |
LIG_BRCT_BRCA1_1 | 110 | 114 | PF00533 | 0.618 |
LIG_BRCT_BRCA1_1 | 65 | 69 | PF00533 | 0.487 |
LIG_BRCT_BRCA1_2 | 110 | 116 | PF00533 | 0.379 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.571 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.588 |
LIG_FHA_2 | 141 | 147 | PF00498 | 0.371 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.475 |
LIG_LIR_Gen_1 | 111 | 118 | PF02991 | 0.383 |
LIG_LIR_Gen_1 | 184 | 194 | PF02991 | 0.625 |
LIG_LIR_Gen_1 | 196 | 206 | PF02991 | 0.510 |
LIG_LIR_Gen_1 | 65 | 71 | PF02991 | 0.439 |
LIG_LIR_Gen_1 | 7 | 15 | PF02991 | 0.531 |
LIG_LIR_Nem_3 | 111 | 117 | PF02991 | 0.633 |
LIG_LIR_Nem_3 | 184 | 190 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 65 | 70 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 7 | 13 | PF02991 | 0.533 |
LIG_PDZ_Class_2 | 236 | 241 | PF00595 | 0.533 |
LIG_Pex14_2 | 183 | 187 | PF04695 | 0.612 |
LIG_Pex14_2 | 190 | 194 | PF04695 | 0.507 |
LIG_SH2_STAP1 | 108 | 112 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.635 |
LIG_SH3_3 | 228 | 234 | PF00018 | 0.585 |
LIG_SUMO_SIM_anti_2 | 137 | 143 | PF11976 | 0.532 |
LIG_SUMO_SIM_anti_2 | 236 | 241 | PF11976 | 0.640 |
LIG_SUMO_SIM_par_1 | 76 | 83 | PF11976 | 0.502 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.617 |
MOD_CK2_1 | 129 | 135 | PF00069 | 0.622 |
MOD_CK2_1 | 23 | 29 | PF00069 | 0.491 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.368 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.617 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.608 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.379 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.470 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.654 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.485 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.420 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.412 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.615 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.511 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.621 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.429 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.632 |
MOD_NEK2_2 | 28 | 33 | PF00069 | 0.417 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.618 |
MOD_PIKK_1 | 163 | 169 | PF00454 | 0.629 |
MOD_PKA_1 | 129 | 135 | PF00069 | 0.370 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.622 |
MOD_Plk_1 | 106 | 112 | PF00069 | 0.607 |
MOD_Plk_1 | 134 | 140 | PF00069 | 0.608 |
MOD_Plk_1 | 174 | 180 | PF00069 | 0.530 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.673 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.396 |
MOD_Plk_4 | 223 | 229 | PF00069 | 0.431 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.745 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.708 |
MOD_SUMO_rev_2 | 119 | 127 | PF00179 | 0.640 |
MOD_SUMO_rev_2 | 153 | 158 | PF00179 | 0.675 |
MOD_SUMO_rev_2 | 200 | 205 | PF00179 | 0.622 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.639 |
TRG_NLS_MonoExtC_3 | 128 | 133 | PF00514 | 0.383 |
TRG_NLS_MonoExtN_4 | 129 | 134 | PF00514 | 0.374 |
TRG_Pf-PMV_PEXEL_1 | 122 | 126 | PF00026 | 0.652 |
TRG_Pf-PMV_PEXEL_1 | 203 | 207 | PF00026 | 0.525 |
TRG_Pf-PMV_PEXEL_1 | 44 | 48 | PF00026 | 0.638 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7WWW7 | Leishmania donovani | 74% | 100% |
A4HZG4 | Leishmania infantum | 73% | 100% |
E9AVF4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 98% |
Q4QC25 | Leishmania major | 72% | 100% |